About
OxyPrem AG is a Swiss medical technology company dedicated to enhancing the care of premature infants through advanced brain oxygen monitoring. Their mission focuses on improving survival rates and long-term health outcomes by providing clinicians with accurate data on brain oxygen saturation. This enables timely interventions to prevent potential brain and organ damage in vulnerable patients. The company's flagship product, the OxyPrem 1.4 tissue oximeter system, is a non-invasive, reusable device that measures oxygen levels in the brain tissue of preterm infants. Designed for continuous monitoring, it alerts medical staff when oxygen supply falls outside safe ranges, addressing a critical need in neonatal care. OxyPrem AG originated as a spin-off from the University of Zurich and has achieved significant milestones, including CE mark certification and ISO 13485:2016 quality certification. OxyPrem's products are primarily aimed at neonatal intensive care units and hospitals worldwide, supporting healthcare providers in making informed decisions to reduce the risk of disabilities associated with oxygen supply issues.
Technologies
Keywords
Company Information
-
Employees 17
-
Founded 2018
-
Total Funding $110648
Location
10 Wiesenstrasse, Schlieren, Zurich, Switzerland, 8952
